Table 2 Number and percentage of pulmonary lesions in CGD patient with different pathogens.
S (%) n = 6 | K (%) n = 3 | Fungi (%) n = 27 | TB (%) n = 7 | |
|---|---|---|---|---|
Consolidation | 2 (33.33) | 3 (100.00) | 17 (62.96) | 5 (71.43) |
Ground-glass opacity | 4 (66.67) | 3 (100.00) | 22 (81.48) | 4 (57.14) |
Nodules | 4 (66.67) | 2 (66.67) | 21 (77.78) | 5 (71.43) |
Mass | 2 (33.33) | 2 (66.67) | 20 (74.07) | 4 (57.14) |
Cavity | 2 (33.33) | 1 (33.33) | 3 (11.11) | 1 (14.29) |
Tree-in-bud opacities | 0 | 0 | 3 (11.11) | 0 |
Bronchiectasis | 1 (16.67) | 0 | 7 (25.93) | 3 (42.86) |
Emphysema | 1 (16.67 ) | 0 | 7 (25.93) | 4 (57.14) |
Scarring | 3 (50.00) | 2 (66.67) | 13 (48.15) | 5 (71.43) |
Mediastinal or hilar lymphadenopathy | 5 (83.33) | 2 (66.67) | 24 (88.89) | 6 (85.71) |
Pulmonary calcification | 1 (16.67) | 1 (33.33) | 7 (25.93) | 3 (42.85) |
Mediastinal lymph node calcification | 0 | 0 | 5 (18.52) | 3 (42.85) |
Pleural thickening | 2 (33.33) | 2 (66.67) | 11 (40.74) | 4 (57.14) |
